Zilucoplan (Zilbrysq) (AChR-positive gMG)

Company: UCB

Clinical trial(s): RAISE (Stage 3 complete) More information

NICE status: Negative final draft guidance published after three committee meetings, myaware have appealed this decision, and the appeal has been upheld. We are now awaiting instructions from NICE regarding the fourth committee meeting.

MHRA status: Approved

Learn more about Zilucoplan.